MEI Pharma, Inc.

    MEI Pharma, Inc.

    NNASDAQ:MEIP
    2.60
    USD
    +0.04
    (+1.56%)

    Share Statistics

    As of June 30, 2025, MEI Pharma, Inc. has 6.66M shares outstanding.

    Shares Outstanding6.66M

    Valuation Ratios

    These figures are as of June 30, 2025.

    PB Ratio-0.04
    P/TBV Ratio0.97
    P/FCF Ratio-0.79
    P/OCF Ratio-0.79

    Financial Position

    As of June 30, 2025, MEI Pharma, Inc. maintains a current ratio of 13.50, meaning it holds 13.5x the short-term assets needed to cover near-term liabilities.

    Current Ratio13.50
    Quick Ratio13.30

    Financial Efficiency

    These figures cover the twelve months ended June 30, 2025. Return on assets (ROA) is negative at -53.45, reflecting losses generated across the asset base.

    Return on Assets (ROA)-53.45

    Stock Price Statistics

    USD

    As of the close on October 6, 2025, MEI Pharma, Inc.'s stock has declined approximately 7.47% over the past 52 weeks. The 50-day moving average sits at 4.00, while the 200-day moving average is 2.94.

    52-Week Price Change-7.47%
    50-Day Moving Average4.00
    200-Day Moving Average2.94

    Dividends & Yields

    These figures cover the twelve months ended June 30, 2025. Free cash flow yield is negative at -126.65: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow.

    FCF Yield-126.65

    Stock Splits

    MEI Pharma, Inc.'s most recent stock split took place on April 17, 2023 with a 20:1 split ratio.

    Last Split Date4/17/2023
    Split Ratio20:1

    Scores

    As of June 30, 2025, MEI Pharma, Inc. has an Altman Z-Score of -25.69, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

    Altman Z-Score-25.69